IRVINE, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Endocare, Inc. (Nasdaq: ENDO), an innovative medical device company focused on the development of minimally invasive technologies for tissue and tumor ablation, today announced that management is scheduled to make an investor presentation at the 2nd Annual OneMedForum at 11:00 a.m. PT on Tuesday, January 13, 2009. The conference is being held at the Sir Francis Drake hotel January 13-14 in San Francisco.
A live webcast of the presentation at the conference will be available via a link provided at http://ir.endocare.com/events.cfm. An archived replay of the presentation will be available shortly after the presentation time for a period of 30 days. Web participants are encouraged to go to Endocare's website (http://ir.endocare.com/events.cfm) at least 15 minutes prior to the start of the call to register, download and install any necessary audio software.
Hosted by OneMedPlace, OneMedForum is a finance conference for emerging medtech companies. OneMedPlace (http://www.onemedplace.com) is a virtual community of healthcare and life science companies. It has, for the first time, put in place the innovations that will shape the future of health and medicine--emerging companies and technologies seeking capital, distribution, visibility and resources to help finance, build and grow, and investors and strategic partners looking for health and medical innovations to invest in, acquire, license, distribute, purchase or utilize.
Endocare, Inc. - www.endocare.com - is an innovative medical device company providing minimally invasive technologies for tissue and tumor ablation. Endocare has initially concentrated on developing technologies for the treatment of prostate cancer and believes that its proprietary technologies have broad applications across a number of markets, including the ablation of tumors in the kidney, lung and liver and palliative intervention (treatment of pain associated with metastases).
Investor Contact: Matt Clawson Allen & Caron, Inc. (949) 474-4300 email@example.com www.allencaron.com Media Contact: Len Hall Allen & Caron, Inc. (949) 474-4300 firstname.lastname@example.org www.allencaron.com For Additional Information: Terrence A. Noonan, Interim CEO Michael R. Rodriguez, CFO Endocare, Inc. (949) 450-5400 www.endocare.com
|SOURCE Endocare, Inc.|
Copyright©2009 PR Newswire.
All rights reserved